These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neural grafting in a rat model of Huntington's disease: striosomal-like organization of striatal grafts as revealed by acetylcholinesterase histochemistry, immunocytochemistry and receptor autoradiography. Isacson O, Dawbarn D, Brundin P, Gage FH, Emson PC, Björklund A. Neuroscience; 1987 Aug; 22(2):481-97. PubMed ID: 2823174 [Abstract] [Full Text] [Related]
3. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum--I. Subcortical afferents. Wictorin K, Isacson O, Fischer W, Nothias F, Peschanski M, Björklund A. Neuroscience; 1988 Nov; 27(2):547-62. PubMed ID: 2464147 [Abstract] [Full Text] [Related]
4. Afferent and efferent connections of striatal grafts implanted into the ibotenic acid lesioned neostriatum in adult rats. Pritzel M, Isacson O, Brundin P, Wiklund L, Björklund A. Exp Brain Res; 1986 Nov; 65(1):112-26. PubMed ID: 2433142 [Abstract] [Full Text] [Related]
5. Fetal striatal neurons grafted into the ibotenate lesioned adult striatum: efferent projections and synaptic contacts in the host globus pallidus. Wictorin K, Clarke DJ, Bolam JP, Björklund A. Neuroscience; 1990 Nov; 37(2):301-15. PubMed ID: 2133346 [Abstract] [Full Text] [Related]
6. Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger RNA, but not glutamate decarboxylase messenger RNA. Venero JL, Beck KD, Hefti F. Neuroscience; 1994 Jul; 61(2):257-68. PubMed ID: 7969907 [Abstract] [Full Text] [Related]
7. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease. Araujo DM, Hilt DC. Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371 [Abstract] [Full Text] [Related]
12. Neurotransmitter-related gene expression in intrastriatal striatal transplants--I. Phenotypical characterization of striatal and non-striatal graft regions. Campbell K, Wictorin K, Björklund A. Neuroscience; 1995 Jan; 64(1):17-33. PubMed ID: 7708203 [Abstract] [Full Text] [Related]
13. Effects of short- and long-term ganglioside treatment on the recovery of neurochemical markers in the ibotenic acid-lesioned rat striatum. Contestabile A, Virgili M, Migani P, Barnabei O. J Neurosci Res; 1990 Aug; 26(4):483-7. PubMed ID: 1977926 [Abstract] [Full Text] [Related]
14. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease. Hughes PE, Alexi T, Williams CE, Clark RG, Gluckman PD. Neuroscience; 1999 Aug; 92(1):197-209. PubMed ID: 10392842 [Abstract] [Full Text] [Related]
15. Cortical modulation of striatal function. Scatton B, Worms P, Lloyd KG, Bartholini G. Brain Res; 1982 Jan 28; 232(2):331-43. PubMed ID: 6200179 [Abstract] [Full Text] [Related]
17. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat. Sperk G, Berger M, Hörtnagl H, Hornykiewicz O. Eur J Pharmacol; 1981 Sep 24; 74(4):279-86. PubMed ID: 6170518 [Abstract] [Full Text] [Related]
19. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts. Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, Poewe W, Wenning GK. Neuroscience; 2000 Sep 24; 95(2):377-88. PubMed ID: 10658617 [Abstract] [Full Text] [Related]